| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |